This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 24/2/257    most recent 01.ATV.0000109170.43400.2fv1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, Y. Articles by Chen, Y. E. Search for Related Content PubMed PubMed Citation Articles by Lin, Y. Articles by Chen, Y. E. Related Collections Remodeling Restenosis Gene expression Gene regulation Mechanism of atherosclerosis/growth factors Other Vascular biology

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:257.)
© 2004 American Heart Association, Inc.

Vascular Biology

Interferon Regulatory Factor-1 Mediates PPAR-Induced Apoptosis in Vascular Smooth Muscle Cells

Yiming Lin; Xiaojun Zhu; Farron L. Mclntee; Hailian Xiao; Jifeng Zhang; Mingui Fu; Yuqing E. Chen

From the Cardiovascular Research Institute (Y.L., F.L.M., H.X., J.Z., M.F., Y.E.C.), Morehouse School of Medicine, Atlanta, GA and the Cardiovascular Research Institute (X.Z., Y.E.C.), Peking University Health Science Center, Beijing 100083, China.

Correspondence to Yuqing E. Chen, Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310. E-mail echen{at}msm.edu

Objective— Peroxisome proliferator-activated receptor (PPAR) possesses general beneficial effects on the cardiovascular system, such as inhibition of vascular lesion formation and atherosclerosis. However, molecular mechanisms for these effects are yet to be fully defined. The aim of this study is to elucidate whether interferon regulatory factor-1 (IRF-1), a transcriptional factor with anti-proliferative and pro-apoptotic properties, mediates PPAR-induced apoptosis in vascular smooth muscle cells (VSMCs).

Methods and Results— Using Northern and Western blot analyses, we documented that PPAR ligands, including ciglitazone, troglitazone, and GW7845, significantly increased IRF-1 expression in VSMCs; however, the PPAR ligand (Wy14643) and PPAR ligand (GW0742) did not affect its expression. PPAR-induced IRF-1 expression was abrogated by pretreatment with the PPAR antagonist GW9662. In contrast, adenoviral expression of PPAR in VSMCs dramatically increased IRF-1 level. Furthermore, PPAR activation increased IRF-1 promoter activity but did not affect IRF-1 mRNA stability. Finally, reducing IRF-1 expression by antisense technology attenuated PPAR-induced VSMC apoptosis through decreasing cyclin-dependent kinase inhibitor p21^cip1 and caspase-3 activity.

Conclusion— Our data demonstrate that IRF-1 is a novel PPAR target gene and mediates PPAR-induced VSMC apoptosis.

Key Words: peroxisome proliferator-activated receptor • interferon regulatory factor-1 • vascular smooth muscle cells • gene expression • apoptosis • atherosclerosis

This article has been cited by other articles:

				Y.-M. Sue, C.-P. Chung, H. Lin, Y. Chou, C.-Y. Jen, H.-F. Li, C.-C. Chang, and S.-H. Juan PPAR{delta}-mediated p21/p27 induction via increased CREB-binding protein nuclear translocation in beraprost-induced antiproliferation of murine aortic smooth muscle cells Am J Physiol Cell Physiol, August 1, 2009; 297(2): C321 - C329. [Abstract] [Full Text] [PDF]

				S. Z. Duan, M. G. Usher, and R. M. Mortensen Peroxisome Proliferator-Activated Receptor-{gamma}-Mediated Effects in the Vasculature Circ. Res., February 15, 2008; 102(3): 283 - 294. [Abstract] [Full Text] [PDF]

				E. Ruiz, S. Redondo, A. Gordillo-Moscoso, and T. Tejerina Pioglitazone Induces Apoptosis in Human Vascular Smooth Muscle Cells from Diabetic Patients Involving the Transforming Growth Factor-beta/Activin Receptor-Like Kinase-4/5/7/Smad2 Signaling Pathway J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 431 - 438. [Abstract] [Full Text] [PDF]

				I. Imayama, T. Ichiki, K. Inanaga, H. Ohtsubo, K. Fukuyama, H. Ono, Y. Hashiguchi, and K. Sunagawa Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor {gamma} Cardiovasc Res, October 1, 2006; 72(1): 184 - 190. [Abstract] [Full Text] [PDF]

				G. G. Loots and I. Ovcharenko Dcode.org anthology of comparative genomic tools Nucleic Acids Res., July 1, 2005; 33(suppl_2): W56 - W64. [Abstract] [Full Text] [PDF]

				R. Wessely Interference by interferons: Janus faces in vascular proliferative diseases Cardiovasc Res, June 1, 2005; 66(3): 433 - 443. [Abstract] [Full Text] [PDF]

				S. Redondo, E. Ruiz, C. G. Santos-Gallego, E. Padilla, and T. Tejerina Pioglitazone Induces Vascular Smooth Muscle Cell Apoptosis Through a Peroxisome Proliferator-Activated Receptor-{gamma}, Transforming Growth Factor-{beta}1, and a Smad2-Dependent Mechanism Diabetes, March 1, 2005; 54(3): 811 - 817. [Abstract] [Full Text] [PDF]